FDA Issues Urgent Recall for Over 2 Million MadeGood Granola Bars
The U.S. Food and Drug Administration has updated its recall for over 2 million cases of MadeGood granola bars due to potential metal contamination. Originally announced in December, the recall has now been classified as Class II, signifying that the products may cause temporary or reversible health issues, although the risk of serious consequences is considered remote.
These popular granola bars, available on platforms like Amazon and in major retailers including Target, Whole Foods, Wegmans, and CVS, include flavors such as chocolate chip, cookies & crème, and mixed berry. The recall affects products manufactured between January and November 2024.
Consumers who have purchased the affected granola bars are advised to return them to the retailer for a full refund. MadeGood has emphasized that while there is a very small risk of contamination, they are taking precautionary measures to ensure customer safety. No injuries have been reported in connection with this issue.
In a statement, MadeGood noted that they conducted an extensive investigation into the manufacturing process and identified the source of the contamination. The company has taken corrective actions and tested new procedures to prevent future occurrences.
This recall serves as a reminder for consumers to check their pantry and ensure any affected products are returned promptly.
2026-09-20
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
Brazil Expands Chemical Tax Breaks as India’s Crop Protection Industry Warns of a 25% Cost Increase
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants
-
关于加强防范钓鱼邮件的通知 Notification on Strengthening Anti-Phishing Measures
-
The FDA Officially Blesses AI for Liver Drug Development
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
Recommend Reading
-
FDA Slows Two Natural Color Approvals, but the Additive Shift Is Still Moving
-
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
-
U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods
-
Geopolitical Easing and Weak Supply and Demand Lead to a Significant Drop in International Oil Prices on Tuesday
-
Costs Decline—DOP Prices Stop Rising and Begin to Fall This Week
-
Both Supply and Demand Weak, Toluene Market Experiences Volatile Decline
-
Styrene Market Shakes and Falls This Week (Apr. 6–10)
-
China's Marine Fuel Market Prices Slightly Increased in February